[CAS NO. 55-10-7]  Vanillylmandelicacid

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [55-10-7]

Fulfillment
Catalog
HY-113121
Brand
MCE
CAS
55-10-7

DESCRIPTION [55-10-7]

Overview

MDLMFCD00004235
Molecular Weight198.17
Molecular FormulaC9H10O5
SMILESO=C(O)C(O)C1=CC=C(O)C(OC)=C1

For research use only. We do not sell to patients.

Summary

Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter metabolism as well. Vanillylmandelic acid has antioxidant activity towards DPPH radical with an IC 50 value of 33 μM [1] .


IC50 & Target

Human Endogenous Metabolite

Microbial Metabolite


In Vitro

Vanillylmandelic acid has antioxidant activity, the IC 50 value is determined as the amount of VMA required to reduce 50% of the starting concentration of free radical is 33*10 -6 M in the UV-Vis decolourisation DPPH assay [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Vanillylmandelic acid (intra-arterial injection over 1 min; 1, 10 and 100 mg/kg; the 60 min-observation period) produces a significant difference between vanillylmandelic acid groups and controls. Vanillylmandelic acid decreases the heart rate by 17.5%, 17.9% and 18.9% after 1, 10 and 100 mg/kg, respectively. Mean blood pressure is decreased by 13.5% in control animals as compared to 37%, 23% and 26% after 1, 10 and 100 mg/kg, respectively, in wistar rats [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL ( 1261.54 mM ; Need ultrasonic)

H 2 O : 100 mg/mL ( 504.62 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 5.0462 mL 25.2309 mL 50.4617 mL
5 mM 1.0092 mL 5.0462 mL 10.0923 mL
10 mM 0.5046 mL 2.5231 mL 5.0462 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 25 mg/mL (126.15 mM); Clear solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (10.50 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (10.50 mM); Clear solution

  • 4.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (10.50 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Benzeneacetic acid, α,4-dihydroxy-3-methoxy-
Mandelic acid, 4-hydroxy-3-methoxy-
α,4-Dihydroxy-3-methoxybenzeneacetic acid
HMMA
4-Hydroxy-3-methoxymandelic acid
Vanillomandelic acid
Vanillylmandelic acid
Vanilmandelic acid
VMA
Vanillinmandelic acid
(4-Hydroxy-3-methoxyphenyl)glycolic acid
3-Methoxy-4-hydroxyphenylhydroxyacetic acid
4′-Hydroxy-3′-methoxymandelic acid
DL-3-Methoxy-4-hydroxymandelic acid
DL-Vanillylmandelic acid
4-Hydroxy-3-methoxy-DL-mandelic acid
(±)-3-Methoxy-4-hydroxymandelic acid
DL-4-Hydroxy-3-methoxymandelic acid
dl-4-Hydroxy-3-methoxymandelic acid (dl-vanillylmandelic acid)
(±)-4-Hydroxy-3-methoxymandelic acid
DL-Vanillomandelic acid
dl-Vanillomandelic acid
(±)-Vanilmandelic acid
Vanillyl-dl-mandelic acid
2-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid
2-(4′-Hydroxy-3′-methoxyphenyl)-2-hydroxyethanoic acid